[{"evidenceId":11621,"evidenceType":"GENE_SUMMARY","shortDesc":null,"desc":"JAK3 encodes a tyrosine kinase involved in cell growth, development and differentiation. Mutations of JAK3 mutations are found in T-cell associated leukemias, lymphomas and various solid tumors.","id":null,"lastEdit":"2017-01-17","status":null,"gene":{"entrezGeneId":3718,"hugoSymbol":"JAK3","name":"Janus kinase 3","oncogene":false,"curatedIsoform":"ENST00000458235","curatedRefSeq":"NM_000215.3","geneAliases":["JAK3_HUMAN","L-JAK","JAKL","JAK-3","LJAK"],"tsg":false},"articles":[]},{"evidenceId":11622,"evidenceType":"GENE_BACKGROUND","shortDesc":null,"desc":"JAK3 encodes for Janus Kinase 3, a non-receptor tyrosine kinase. JAK3 activation results in activation of the STAT family of proteins (PMID:8986719) and can also signal through the MAPK and AKT pathways (PMID:22120524). JAK3 regulates response to cytokines, chemokines, and metabolism (PMID:8022486, 24498424, 25493954, 26451047). JAK3 signaling plays a crucial role in T-cell development, including regulation of T-cell apoptosis (PMID:11134353). Clinically JAK3 signaling can mediate autoimmune disease and graft rejection (PMID:14593182, 26230873). JAK3 mutations are seen in acute leukemias (PMID:22237106, 16843266), myeloid and lymphoid leukemia subtypes (PMID:23832011, 24446122), and lymphomas (PMID:24837469, 23689514). JAK3 mutations are also found in solid tumors but at lower incidence (PMID:18559588, 26096009, 24821835, 21868263). Loss of function mutations in JAK3 can lead to severe combined immunodeficiency (SCID) (PMID:10075926).","id":null,"lastEdit":"2017-01-17","status":null,"gene":{"entrezGeneId":3718,"hugoSymbol":"JAK3","name":"Janus kinase 3","oncogene":false,"curatedIsoform":"ENST00000458235","curatedRefSeq":"NM_000215.3","geneAliases":["JAK3_HUMAN","L-JAK","JAKL","JAK-3","LJAK"],"tsg":false},"articles":[{"pmid":"8022486","title":"Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.","journal":"Nature","pubDate":"1994 Jul 14","volume":"370","issue":"6485","pages":"153-7","authors":"Witthuhn BA et al","elocationId":"","link":null,"reference":"Witthuhn BA et al. Nature. 1994 Jul 14;370(6485)153-7.","abstract":null},{"pmid":"18559588","title":"Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.","journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","pubDate":"2008 Jun 15","volume":"14","issue":"12","pages":"3716-21","authors":"Jeong EG et al","elocationId":"doi: 10.1158/1078-0432.CCR-07-4839","link":null,"reference":"Jeong EG et al. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Jun 15;14(12)3716-21.","abstract":null},{"pmid":"26451047","title":"Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.","journal":"The Journal of biological chemistry","pubDate":"2015 Dec 4","volume":"290","issue":"49","pages":"29301-12","authors":"Mishra J et al","elocationId":"doi: 10.1074/jbc.M115.670331","link":null,"reference":"Mishra J et al. The Journal of biological chemistry. 2015 Dec 4;290(49)29301-12.","abstract":null},{"pmid":"26096009","title":"Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next generation sequencing.","journal":"Molecular medicine reports","pubDate":"2015 Sep","volume":"12","issue":"3","pages":"4678-82","authors":"Lu J et al","elocationId":"doi: 10.3892/mmr.2015.3952","link":null,"reference":"Lu J et al. Molecular medicine reports. 2015 Sep;12(3)4678-82.","abstract":null},{"pmid":"23689514","title":"JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.","journal":"Leukemia","pubDate":"2014 Feb","volume":"28","issue":"2","pages":"338-48","authors":"Bouchekioua A et al","elocationId":"doi: 10.1038/leu.2013.157","link":null,"reference":"Bouchekioua A et al. Leukemia. 2014 Feb;28(2)338-48.","abstract":null},{"pmid":"8986719","title":"Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.","journal":"Immunity","pubDate":"1996 Dec","volume":"5","issue":"6","pages":"605-15","authors":"Oakes SA et al","elocationId":"","link":null,"reference":"Oakes SA et al. Immunity. 1996 Dec;5(6)605-15.","abstract":null},{"pmid":"22120524","title":"Role of JAK3 in myogenic differentiation.","journal":"Cellular signalling","pubDate":"2012 Mar","volume":"24","issue":"3","pages":"742-9","authors":"Jang YN et al","elocationId":"doi: 10.1016/j.cellsig.2011.11.009","link":null,"reference":"Jang YN et al. Cellular signalling. 2012 Mar;24(3)742-9.","abstract":null},{"pmid":"11134353","title":"Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.","journal":"Molecular and cellular biology","pubDate":"2001 Jan","volume":"21","issue":"2","pages":"678-89","authors":"Wen R et al","elocationId":"","link":null,"reference":"Wen R et al. Molecular and cellular biology. 2001 Jan;21(2)678-89.","abstract":null},{"pmid":"22237106","title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.","journal":"Nature","pubDate":"2012 Jan 11","volume":"481","issue":"7380","pages":"157-63","authors":"Zhang J et al","elocationId":"doi: 10.1038/nature10725","link":null,"reference":"Zhang J et al. Nature. 2012 Jan 11;481(7380)157-63.","abstract":null},{"pmid":"16843266","title":"Activating alleles of JAK3 in acute megakaryoblastic leukemia.","journal":"Cancer cell","pubDate":"2006 Jul","volume":"10","issue":"1","pages":"65-75","authors":"Walters DK et al","elocationId":"","link":null,"reference":"Walters DK et al. Cancer cell. 2006 Jul;10(1)65-75.","abstract":null},{"pmid":"26230873","title":"Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases.","journal":"Journal of medicinal chemistry","pubDate":"2015 Sep 24","volume":"58","issue":"18","pages":"7195-216","authors":"Farmer LJ et al","elocationId":"doi: 10.1021/acs.jmedchem.5b00301","link":null,"reference":"Farmer LJ et al. Journal of medicinal chemistry. 2015 Sep 24;58(18)7195-216.","abstract":null},{"pmid":"14593182","title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.","journal":"Science (New York, N.Y.)","pubDate":"2003 Oct 31","volume":"302","issue":"5646","pages":"875-8","authors":"Changelian PS et al","elocationId":"","link":null,"reference":"Changelian PS et al. Science (New York, N.Y.). 2003 Oct 31;302(5646)875-8.","abstract":null},{"pmid":"25493954","title":"Janus kinase 3 regulates renal 25-hydroxyvitamin D 1α-hydroxylase expression, calcitriol formation, and phosphate metabolism.","journal":"Kidney international","pubDate":"2015 Apr","volume":"87","issue":"4","pages":"728-37","authors":"Umbach AT et al","elocationId":"doi: 10.1038/ki.2014.371","link":null,"reference":"Umbach AT et al. Kidney international. 2015 Apr;87(4)728-37.","abstract":null},{"pmid":"24821835","title":"Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.","journal":"Clinical chemistry","pubDate":"2014 Jul","volume":"60","issue":"7","pages":"1004-11","authors":"Liu X et al","elocationId":"doi: 10.1373/clinchem.2014.225565","link":null,"reference":"Liu X et al. Clinical chemistry. 2014 Jul;60(7)1004-11.","abstract":null},{"pmid":"23832011","title":"Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.","journal":"Nature genetics","pubDate":"2013 Aug","volume":"45","issue":"8","pages":"937-41","authors":"Sakaguchi H et al","elocationId":"doi: 10.1038/ng.2698","link":null,"reference":"Sakaguchi H et al. Nature genetics. 2013 Aug;45(8)937-41.","abstract":null},{"pmid":"24498424","title":"Jak3 enables chemokine-dependent actin cytoskeleton reorganization by regulating cofilin and Rac/Rhoa GTPases activation.","journal":"PloS one","pubDate":"2014","volume":"9","issue":"2","pages":"e88014","authors":"Ambriz-Peña X et al","elocationId":"doi: 10.1371/journal.pone.0088014","link":null,"reference":"Ambriz-Peña X et al. PloS one. 2014;9(2)e88014.","abstract":null},{"pmid":"24446122","title":"Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.","journal":"Genes, chromosomes &amp; cancer","pubDate":"2014 Apr","volume":"53","issue":"4","pages":"309-16","authors":"Bergmann AK et al","elocationId":"doi: 10.1002/gcc.22141","link":null,"reference":"Bergmann AK et al. Genes, chromosomes &amp; cancer. 2014 Apr;53(4)309-16.","abstract":null},{"pmid":"24837469","title":"A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy.","journal":"Haematologica","pubDate":"2014 Sep","volume":"99","issue":"9","pages":"e156-8","authors":"Hanna DM et al","elocationId":"doi: 10.3324/haematol.2014.108142","link":null,"reference":"Hanna DM et al. Haematologica. 2014 Sep;99(9)e156-8.","abstract":null},{"pmid":"21868263","title":"JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications.","journal":"Urologic oncology","pubDate":"2013 Aug","volume":"31","issue":"6","pages":"930-7","authors":"de Martino M et al","elocationId":"doi: 10.1016/j.urolonc.2011.07.001","link":null,"reference":"de Martino M et al. Urologic oncology. 2013 Aug;31(6)930-7.","abstract":null},{"pmid":"10075926","title":"Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.","journal":"The EMBO journal","pubDate":"1999 Mar 15","volume":"18","issue":"6","pages":"1549-58","authors":"Cacalano NA et al","elocationId":"","link":null,"reference":"Cacalano NA et al. The EMBO journal. 1999 Mar 15;18(6)1549-58.","abstract":null}]}]